Printed From BioPortfolio.com
Lung Cancer Video Library – Is There A Role For PD-L1 Testing After First Line Treatment For Advanced Non-Small Cell Lung Cancer (NSCLC) In Those Previously Untested
19:00 EDT 1 Nov 2017 | GRACE
Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses Is There A Role For PD-L1 Testing After First Line Treatment For Advanced Non-Small Cell Lung Cancer (NSCLC) In Those Previously Untested.
Related Posts:
Why Give Adjuvant Chemotherapy, and to Which Patients? April 5, 2016 
Lymph Node Occult Metastatic Spread: Predictive of… October 17, 2011 
Modifying Factors: Should Patients with Smaller… May 15, 2012 
Risk/Benefit from Adjuvant Chemo for Early Stage NSCLC: June 13, 2009 
NATCH: Good Question, Bad Trial July 7, 2010
